Drug intelligence / Profile preview

wubi shanyao pill

Development stage
Unknown
Lead developer
Huqing Yutang
Administration
Oral
01

Overview

Wubi Shanyao Pill is a Traditional Chinese Medicine (TCM) herbal formula traditionally used to treat kidney-related conditions, particularly those characterized by spleen and kidney deficiency. The formula typically comprises several botanical ingredients, including *Dioscorea opposita* (Shanyao), *Rehmannia glutinosa*, *Cistanche deserticola*, *Cuscuta chinensis*, *Poria cocos*, *Achyranthes bidentata*, and *Alisma plantago-aquatica*. In modern clinical research, it is being investigated for its potential to reduce proteinuria and slow the progression of kidney failure in patients with IgA nephropathy who are at moderate to high risk of renal decline. The formula is thought to exert its therapeutic effects through multi-target mechanisms involving immunomodulation and anti-inflammatory pathways, although specific molecular targets for the entire combination are not fully defined in a Western pharmacological context.

Other names
Wubi Shanyao WanWubishanyao PillWubishanyao Wan
02

Targets

PCNA (Proliferating cell nuclear antigen)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)SIRT3 (NAD-dependent protein deacetylase sirtuin-3)FOXO3 (Forkhead box protein O3)TP53 (Cellular Tumor Antigen p53 R175H)

Beyond the preview

Go deeper on wubi shanyao pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on wubi shanyao pill.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call